The emergence of non-alcoholic fatty liver disease (NAFLD) as the leading chronic liver
disease worldwide raises some concerns. In particular, NAFLD is closely tied to sedentary …

HCC is a heterogeneous group of tumors in terms of histology, genetic aberration, and
protein expression. Advancements in imaging techniques have allowed imaging diagnosis …

Purpose To compare radiofrequency ablation (RFA) with or without transcatheter arterial
chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). Patients …

Background Immune checkpoint inhibitors (ICIs) have revolutionized treatment of advanced
hepatocellular carcinoma. Integrated use of transarterial chemoembolization (TACE), a …

Hepatocellular carcinoma (HCC) is the most common primary liver neoplasm and one of the
most common causes of death in patients with cirrhosis of the liver. In parallel with …

Background & Aims Sorafenib is associated with multiple adverse events (AEs), potentially
causing its permanent interruption. It is unknown how physicians' experience has impacted …

(1) Background: Patients with advanced chronic liver disease (ACLD) are living longer with
more comorbidities because of improved medical and surgical management. However …

Hepatocellular carcinoma (HCC) is the most common primary liver neoplasm and one of the
most common causes of death in patients with cirrhosis of the liver. In parallel, with …

The treatment of hepatocellular carcinoma (HCC) has witnessed radical changes over the
last few years, with the introduction of immune checkpoint inhibitors (ICI) in clinical practice …

Sarcopenia has been associated with lower overall survival in patients with cirrhosis and
hepatocellular carcinoma (HCC) undergoing surgical resection, TACE, TARE, or …